Schuster BG - Search Results

1

Mechanism of cardiotoxicity of halofantrine.

Wesche DL, Schuster BG, Wang WX, Woosley RL. Wesche DL, et al. Among authors: schuster bg. Clin Pharmacol Ther. 2000 May;67(5):521-9. doi: 10.1067/mcp.2000.106127. Clin Pharmacol Ther. 2000. PMID: 10824631 Review.

2

Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation.

Abernethy DR, Wesche DL, Barbey JT, Ohrt C, Mohanty S, Pezzullo JC, Schuster BG. Abernethy DR, et al. Among authors: schuster bg. Br J Clin Pharmacol. 2001 Mar;51(3):231-7. doi: 10.1046/j.1365-2125.2001.00351.x. Br J Clin Pharmacol. 2001. PMID: 11298069 Free PMC article. Clinical Trial.

3

Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers.

Anderson SL, Berman J, Kuschner R, Wesche D, Magill A, Wellde B, Schneider I, Dunne M, Schuster BG. Anderson SL, et al. Among authors: schuster bg. Ann Intern Med. 1995 Nov 15;123(10):771-3. doi: 10.7326/0003-4819-123-10-199511150-00005. Ann Intern Med. 1995. PMID: 7574195 Clinical Trial.

4

Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.

Brueckner RP, Coster T, Wesche DL, Shmuklarsky M, Schuster BG. Brueckner RP, et al. Among authors: schuster bg. Antimicrob Agents Chemother. 1998 May;42(5):1293-4. doi: 10.1128/AAC.42.5.1293. Antimicrob Agents Chemother. 1998. PMID: 9593172 Free PMC article. Clinical Trial.

5

Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo.

Andersen SL, Ager A, McGreevy P, Schuster BG, Wesche D, Kuschner R, Ohrt C, Ellis W, Rossan R, Berman J. Andersen SL, et al. Among authors: schuster bg. Am J Trop Med Hyg. 1995 Feb;52(2):159-61. doi: 10.4269/ajtmh.1995.52.159. Am J Trop Med Hyg. 1995. PMID: 7872444

6

Pharmacokinetics of an extended-dose halofantrine regimen in patients with malaria and in healthy volunteers.

Ohrt C, Watt G, Teja-Isavadharm P, Keeratithakul D, Loesuttiviboon L, Webster HK, Schuster B, Fleckenstein L. Ohrt C, et al. Clin Pharmacol Ther. 1995 May;57(5):525-32. doi: 10.1016/0009-9236(95)90037-3. Clin Pharmacol Ther. 1995. PMID: 7768075 Clinical Trial.

7

Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans.

Marino MT, Schuster BG, Brueckner RP, Lin E, Kaminskis A, Lasseter KC. Marino MT, et al. Among authors: schuster bg. J Clin Pharmacol. 1998 Mar;38(3):227-35. doi: 10.1002/j.1552-4604.1998.tb04420.x. J Clin Pharmacol. 1998. PMID: 9549661 Clinical Trial.

8

Neurotoxicity in animals due to arteether and artemether.

Brewer TG, Peggins JO, Grate SJ, Petras JM, Levine BS, Weina PJ, Swearengen J, Heiffer MH, Schuster BG. Brewer TG, et al. Among authors: schuster bg. Trans R Soc Trop Med Hyg. 1994 Jun;88 Suppl 1:S33-6. doi: 10.1016/0035-9203(94)90469-3. Trans R Soc Trop Med Hyg. 1994. PMID: 8053022

9

Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.

Shmuklarsky MJ, Klayman DL, Milhous WK, Kyle DE, Rossan RN, Ager AL Jr, Tang DB, Heiffer MH, Canfield CJ, Schuster BG. Shmuklarsky MJ, et al. Among authors: schuster bg. Am J Trop Med Hyg. 1993 Mar;48(3):377-84. doi: 10.4269/ajtmh.1993.48.377. Am J Trop Med Hyg. 1993. PMID: 8470775

10

Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum.

Kuschner RA, Heppner DG, Andersen SL, Wellde BT, Hall T, Schneider I, Ballou WR, Foulds G, Sadoff JC, Schuster B, et al. Kuschner RA, et al. Lancet. 1994 Jun 4;343(8910):1396-7. doi: 10.1016/s0140-6736(94)92526-7. Lancet. 1994. PMID: 7910886 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page